Press releases

Month Year

Email alerts

Oct 14, 2014

Medtronic Begins Pivotal Study of First Predictive Low Glucose Management Technology for People with Diabetes

In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization

MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough...
Oct 13, 2014

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System's Positive Performance with Low Mortality and Stroke

MINNEAPOLIS and MILAN - Oct. 13, 2014 -Medtronic, Inc. (NYSE: MDT) today announced positive data from nine European centers in a study of the direct aortic approach (through the upper chest) with...
Oct 13, 2014

Covidien Promotes Greater Global Awareness of Thrombosis Risks

Covidien Promotes Greater Global Awareness of Thrombosis Risks

October 13, 2014 12:01 AM Eastern Daylight Time DUBLIN, Ireland--(BUSINESS WIRE)--As part of a global effort to highlight the threat posed by venous thromboembolism (VTE), Covidien plc today...
Oct 10, 2014

Covidien Initiates Voluntary Field Safety Alert for Medi-Trace™ Cadence and Kendall™ Multi-function Defibrillation Electrodes

Dublin, Ireland -- October 10, 2014 – Covidien today announced that it has notified customers of a voluntary Field Safety Alert for certain Medi-Trace™ Cadence and Kendall™ Multi-function...
Oct 10, 2014

Medtronic Announces Executive Leadership Team for Combined Organization Upon Close of Covidien Acquisition

MINNEAPOLIS -- October 10, 2014 -- Medtronic (NYSE: MDT) today announced the executive team who will lead the combined organization following the close of its proposed acquisition of Covidien. The...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa